Differences Between Omicron Infections and Fever Outpatients: Comparison of Clinical Manifestations and Initial Routine Hematology Indicators

References

• Kawaoka Y, Uraki R, Kiso M, et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Res Sq. 2022. doi:10.21203/rs.3.rs-1375091/v1
   Google Scholar
• Wang L, Berger NA, Kaelber DC, et al. Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 years in the US. JAMA Pediatr. 2022;176(8):811–813. doi:10.1001/jamapediatrics.2022.0945
   Web of Science ®Google Scholar
• Koelle K, Martin MA, Antia R, et al. The changing epidemiology of SARS-CoV-2. Science. 2022;375(6585):1116–1121. doi:10.1126/science.abm4915
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399(10340):2011–2012. doi:10.1016/S0140-6736(22)00838-8
   PubMed Web of Science ®Google Scholar
• He X, Hong W, Pan X, et al. SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm. 2021;2(4):838–845. doi:10.1002/mco2.110
   PubMedGoogle Scholar
• Planas D, Saunders N, Maes P, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602(7898):671–675. doi:10.1038/s41586-021-04389-z
   PubMed Web of Science ®Google Scholar
• Shuai H, Chan JF, Hu B, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603(7902):693–699. doi:10.1038/s41586-022-04442-5
   PubMed Web of Science ®Google Scholar
• Jia L, Xu M, Hao M, et al. Comparison of microbial composition and diversity in the upper respiratory tract between SARS-CoV-2 and influenza virus infections[J]. Sci China Life Sci. 2022;65(7):1469–1472. doi:10.1007/s11427-021-2092-1
   Web of Science ®Google Scholar
• Influenza Surveillance: purpose and methods. Available from: https://www.cdc.gov/flu/weekly/overview.htm. Accessed August 18, 2022.
   Google Scholar
• Cai J, Deng X, Yang J, et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med. 2022;28(7):1468–1475. doi:10.1038/s41591-022-01855-7
   Web of Science ®Google Scholar
• Dejnirattisai W, Huo J, Zhou D, et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185(3):467–484. doi:10.1016/j.cell.2021.12.046
   PubMed Web of Science ®Google Scholar
• Torjesen I. Covid-19: omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021;375:n2943. doi:10.1136/bmj.n2943
   PubMed Web of Science ®Google Scholar
• Lu G, Wang J. Dynamic changes in routine blood parameters of a severe COVID-19 case[J]. Clin Chim Acta. 2020;508:98–102. doi:10.1016/j.cca.2020.04.034
   PubMed Web of Science ®Google Scholar
• Huyut M, Üstündağ H. Prediction of diagnosis and prognosis of COVID-19 disease by blood gas parameters using decision trees machine learning model: a retrospective observational study. Med Gas Res. 2022;12(2):60–66. doi:10.4103/2045-9912.326002
   PubMed Web of Science ®Google Scholar
• Huyut MT, Velichko A. Diagnosis and Prognosis of COVID-19 disease using routine blood values and LogNNet neural network. Sensors. 2022;22(13):4820. doi:10.3390/s22134820
   PubMed Web of Science ®Google Scholar
• Zhou K, Sun Y, Li L, et al. Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurements. Comput Struct Biotechnol J. 2021;19:3640–3649. doi:10.1016/j.csbj.2021.06.022
   Web of Science ®Google Scholar
• Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and Platelet count. Platelets. 2020;31(5):674–679. doi:10.1080/09537104.2020.1760230
   PubMed Web of Science ®Google Scholar
• Diagnosis and Treatment Protocols for COVID-19 (9th trial edition). Available from: http://www.gov.cn/xinwen/2022-06/28/5698168/files/9585944023424f45a4b4d522b5f5c034.pdf. Accessed August 18, 2022.
   Google Scholar
• Wang L, Berger NA, Kaelber DC, et al. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron. medRxiv. 2022. doi:10.1101/2021.12.30.21268495
   Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 Virus. Cell. 2020;182(4):812–827. doi:10.1016/j.cell.2020.06.043
   PubMed Web of Science ®Google Scholar
• Kim M, Lee B, Choi YY, et al. Clinical characteristics of 40 patients infected with the SARS-CoV-2 Omicron Variant in Korea. J Korean Med Sci. 2022;37(3):e31. doi:10.3346/jkms.2022.37.e31
   Web of Science ®Google Scholar
• Chu H, Yuen K. Pathogenicity of SARS‐CoV‐2 Omicron. Clin Transl Med. 2022 May;12(5):e880. doi:10.1002/ctm2.880
   Web of Science ®Google Scholar
• Carreno JM, Alshammary H, Tcheou J, et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature. 2022;602(7898):682–688. doi:10.1038/s41586-022-04399-5
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Mannar D, Saville JW, Zhu X, et al. SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science. 2022;375(6582):760–764. doi:10.1126/science.abn7760
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Wu Y, Huang X, Sun J, et al. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19. mSphere. 2020;5(4). doi:10.1128/mSphere.00362-20
   Web of Science ®Google Scholar
• Huyut MT, Ilkbahar F. The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease[J]. Int Immunopharmacol. 2021;98:107838. doi:10.1016/j.intimp.2021.107838
   Web of Science ®Google Scholar
• Sun C, Xie C, Bu GL, et al. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Signal Transduct Target Ther. 2022;7(1):202. doi:10.1038/s41392-022-01039-2
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang Y, Chi H, et al. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19 a retrospective study[J]. Clin Chem Lab Med. 2020;58:1106–1115. doi:10.1515/cclm-2020-0377
   PubMed Web of Science ®Google Scholar